scorecardresearchWockhardt Share Price Live NSE, BSE, Today - Wockhardt Stock Price


BSE: 532300 | NSE: WOCKPHARMA | ISIN: INE049B01025 | SECTOR: Biotechnology & Drugs

585.00 11.40 (1.99%)

19 Apr 2024, 09:59 (IST)
  • Open

  • High

  • Low

  • Prev Close

  • P/E

  • Median P/E

  • P/B

  • Median P/B

  • Market Cap

  • Volume

  • Vol. (20 day Avg.)

  • PEG

  • Div.Yield

  • Bid

  • Ask


Promoter Pledge Holding - 27.3%

Promoter NameNo of SharesPercentage
Callirhoe Trustee Company Private Limited10,00,0000.87%
Ananke Trustee Company Private Limited50,0000.03%
Themisto Trustee Company Private Limited4,08,24,80026.66%

Company Description

  • Biotechnology & Drugs
  • BSE

  • NSE

  • ISIN


Wockhardt Limited is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. It manufactures a range of dosage forms, including sterile injectables and lyophilized products. The Company offers products in therapeutic areas of dermatology, cosmeceuticals, oncology, medical nutrition, osteoarthritis, pain management, nephrology, cough therapy and diabetology. The Company’s products across India includes Citawok, Citawok Forte, Citawok Plus, CONSEGNA 30/70 U-200 CART, CONSEGNA R U-200 CART, DARBOTIN PFS, DECDAN, DECDAN B, DECDAN B Injection, DECDAN LITE CREAM, Emrok, Emrok O, Erliso, FOSCHEK-S, Gabawok NT, GLARITUS CART, GLARITUS DISPO, Glimaday, INOGLA, Livatira, GLARITUS CART and VAL 450. It has manufacturing and research facilities in India, United States of America and the United Kingdom and a manufacturing facility in Ireland.

Company Officers

  • Habil Fakhruddin Khorakiwala

    Executive Chairman of the Board
  • Deepak Madnani

    Chief Financial Officer
  • Rashmi Mamtura

    Compliance Officer, Company Secretary
  • Murtaza Habil Khorakiwala

    Managing Director, Executive Director
  • Huzaifa Habil Khorakiwala

    Executive Director